Bone and Joint Health Supplements Market Report 2026

The bone and joint health supplements market size has grown strongly in recent years. It will grow from $14.99 billion in 2025 to $16.46 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of osteoporosis, increasing arthritis cases, growing awareness of bone health, aging population, demand for calcium-fortified products.

The bone and joint health supplements market size is expected to see rapid growth in the next few years. It will grow to $24.12 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to technological innovations in supplement formulations, growth of e-commerce channels, personalized nutrition trends, rising adoption of plant-based supplements, increasing healthcare expenditure. Major trends in the forecast period include personalized bone & joint supplements, plant-based & herbal formulations, anti-inflammatory joint health products, age-specific nutritional supplements, enhanced bioavailability formulations.

The increasing prevalence of osteoporosis is expected to propel the growth of the bone and joint health supplements market going forward. Individuals with low calcium intake are more likely to develop osteoporosis, as lifelong calcium deficiency contributes significantly to reduced bone mass and bone mineral density. Osteoporosis is a condition in which bone quality and structure deteriorate, leading to increased fragility and a higher risk of fractures. Bone and joint health supplements are designed to slow bone loss and, in some cases, help restore bone density, thereby reducing fracture risk. For instance, in June 2025, according to the Royal Osteoporosis Society, a UK-based non-profit organization, an estimated 3.5 million people in the UK are living with osteoporosis. The condition causes approximately 500,000 fractures annually, costing over £4.5 billion each year. Furthermore, around half of women and 20% of men aged over 50 are expected to experience a fracture due to osteoporosis. Therefore, the rising prevalence of osteoporosis is driving the growth of the bone and joint health supplements market.

Major companies operating in the bone and joint health supplements market are focusing on technological advancements such as undenatured (native) type II collagen formulations to enhance joint support, improve mobility, and reduce cartilage degradation. Undenatured type II collagen preserves its natural triple-helix structure, unlike hydrolyzed collagen, and functions through an “oral tolerance” mechanism. In this process, small daily doses (typically around 40 mg) help modulate the immune response in the gut, reducing inflammation-driven cartilage breakdown in joints. For instance, in April 2025, Qualia Life Sciences, a US-based nutraceutical company, launched Qualia Joint Health, an advanced joint supplement formulated with clinically studied ingredients. The product includes native type II collagen, eggshell membrane, hyaluronic acid, glucosamine, and L-carnitine, which collectively support cartilage production, joint lubrication, tendon strength, and healthy aging. This synergistic formulation is designed to promote daily mobility, joint resilience, and long-term musculoskeletal health.

In July 2023, Sanofi, a France-based consumer healthcare company, acquired Qunol for an undisclosed amount. With this acquisition, Sanofi seeks to broaden its vitamin, mineral, and supplement (VMS) portfolio, particularly within the joint health category, by incorporating Qunol’s turmeric-based joint health products. Qunol is a US-based dietary supplement company offering products such as turmeric and CoQ10, with an emphasis on joint health and overall wellness.

Major companies operating in the bone and joint health supplements market are Nature's Bounty Incorporated, The Procter & Gamble Company, Amway Corporation, BASF SE, Archer Daniels Midland Company, Reckitt Benckiser Group PLC, Pfizer Incorporated, Vita Life Sciences Limited, Glanbia PLC, Nutramax Laboratories Consumer Care Incorporated, Koninklijke DSM N.V., Xtend-Life Incorporated, Bergstrom Nutrition Incorporated, BioScience Nutrition Incorporated, Herbs Nutriproducts Private Limited, Arazo Nutrition Incorporated, Vitawin International Holdings Limited, Pure Encapsulations LLC, Abbott Laboratories Incorporated, NutriScience Innovations LLC, Optimum Nutrition Inc., Rainbow Light Nutritional Systems Inc., Schiff Nutrition International Inc., Solgar Vitamin and Herb Co. Inc., Source Naturals Inc., Sports Research Corporation, Swanson Health Products Inc., Twinlab Consolidation Corporation, USANA Health Sciences Inc., Vitacost.com Inc.

North America was the largest region in the bone and joint health supplements market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone and joint health supplements market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bone and joint health supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on imported raw materials and active ingredients have affected the bone and joint health supplements market by increasing production costs and supply chain disruptions. Segments such as calcium, collagen, and glucosamine-chondroitin are most affected, particularly in regions dependent on imports like Asia-Pacific and Europe. While tariffs create cost pressures, they also encourage local manufacturing and domestic sourcing strategies, potentially boosting local industry growth and innovation in supplement formulations.

The bone and joint health supplements market research report is one of a series of new reports that provides bone and joint health supplements market statistics, including bone and joint health supplements industry global market size, regional shares, competitors with a bone and joint health supplements market share, detailed bone and joint health supplements market segments, market trends and opportunities, and any further data you may need to thrive in the bone and joint health supplements industry. This bone and joint health supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bone and joint health supplements include calcium, minerals, and various vitamins such as vitamin D and vitamin K that are essential for maintaining bone health, as they help preserve bone density and prevent joint degeneration. These supplements are used to improve range of motion, reduce arthritis-related pain, accelerate recovery after injuries, and support overall joint health by promoting strong and dense bones.

The primary types of bone and joint health supplements include vitamin D, vitamin K, calcium, collagen, omega-3 fatty acids, glucosamine-chondroitin, and others. Vitamin D supplements are used to regulate the body’s calcium and phosphorus levels and to maintain healthy bone structure. Vitamin D is a fat-soluble vitamin that occurs naturally in certain foods, is added to some foods, and is also available as a dietary supplement. These supplements are available in forms such as tablets, capsules, liquids, powders, and others, and are used in dietary supplements, functional foods and beverages, and other applications. They are distributed through channels including supermarkets and hypermarkets, pharmacies, health stores, convenience stores, internet retailing, and others.

The bone joint and health supplement market consist of sales of anthocyanins, polyphenols, sulforaphane, and diallyl disulfide. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.